These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21382160)

  • 21. Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
    Manolakopoulos S; Bethanis S; Elefsiniotis J; Karatapanis S; Triantos C; Sourvinos G; Touloumi G; Economou M; Vlachogiannakos J; Spandidos D; Avgerinos A; Tzourmakliotis D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):787-95. PubMed ID: 16556181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
    Alvarez-Uria G; Ratcliffe L; Vilar J
    HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
    Jiao ZY; Jiao Z
    Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A].
    Kim JM; Lee YS; Lee JH; Kim W; Lim KS
    Korean J Hepatol; 2008 Dec; 14(4):474-82. PubMed ID: 19119242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the clinical features of and responsive factors on the prognosis in patients with fulminant hepatic failure].
    Zhang L; Han F; Wu D; Zhang D; Feng GH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):614-7. PubMed ID: 20825718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
    Bellini C; Keiser O; Chave JP; Evison J; Fehr J; Kaiser L; Weber R; Vernazza P; Bernasconi E; Telenti A; Cavassini M;
    HIV Med; 2009 Jan; 10(1):12-8. PubMed ID: 18795964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamivudine treatment for acute severe hepatitis B: a pilot study.
    Schmilovitz-Weiss H; Ben-Ari Z; Sikuler E; Zuckerman E; Sbeit W; Ackerman Z; Safadi R; Lurie Y; Rosner G; Tur-Kaspa R; Reshef R
    Liver Int; 2004 Dec; 24(6):547-51. PubMed ID: 15566503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh.
    Mahtab MA; Rahman S; Khan M; Mamun AA; Afroz S
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):161-4. PubMed ID: 18397851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.
    Delić D; Nesić Z; Prostran M; Boricić I; Svirtlih N
    Vojnosanit Pregl; 2009 Mar; 66(3):199-202. PubMed ID: 19341224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.
    Schvoerer E; Kabissa I; Cotto E; Jouvencel AC; Balabaud C; De Ledinghen V; Couzigou P; Quinton A; Schvoerer C; Lafon ME; Fleury H; Bernard PH
    Gastroenterol Clin Biol; 2002 Jan; 26(1):62-6. PubMed ID: 11938042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
    Perrillo R; Rakela J; Dienstag J; Levy G; Martin P; Wright T; Caldwell S; Schiff E; Gish R; Villeneuve JP; Farr G; Anschuetz G; Crowther L; Brown N
    Hepatology; 1999 May; 29(5):1581-6. PubMed ID: 10216146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances in the treatment of fulminant hepatitis B].
    Yoshiba M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():280-3. PubMed ID: 15453330
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of lamivudine for patients with acute hepatitis B (a series of cases).
    Kondili LA; Osman H; Mutimer D
    J Viral Hepat; 2004 Sep; 11(5):427-31. PubMed ID: 15357647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamivudine treatment in infantile fulminant hepatitis B.
    Chen CY; Ni YH; Chen HL; Lu FL; Chang MH
    Pediatr Int; 2010 Aug; 52(4):672-4. PubMed ID: 20958881
    [No Abstract]   [Full Text] [Related]  

  • 39. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
    Jonas MM; Little NR; Gardner SD;
    J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.